Natural and synthetic polyesters for musculoskeletal tissue repair: Experimental in vitro and in vivo evaluations

International Journal of Artificial Organs

Volumn 27, Issue 9, 2004, Pages 796-805

  Giavaresi, Gianluca ^a   Tschon, M ^b   Daly, J H ^a   Liggat, J J ^b   Fini, M ^a   Torricelli, P ^a   Giardino, R ^a  

^a RIZZOLI ORTHOPAEDIC INSTITUTE   (Italy)

^b UNIVERSITY OF STRATHCLYDE   (United Kingdom)

Author keywords

Animal model; Biocompatibility; Implant; Murine fibroblasts; Polyesters

Indexed keywords

CELL CULTURE; CELL PROLIFERATION; COLLAGEN; CYTOTOXICITY; FIBROBLASTS; MEDICAL APPLICATIONS; MUSCULOSKELETAL SYSTEM; POLYESTERS; RATS; REPAIR; TISSUE;

ANIMAL MODEL; CYCLOHEXYL; HYDROXYVALERATE; IMPLANT; IN-VITRO; MURINE FIBROBLASTS; TISSUE REPAIR; TOTAL PROTEIN; VITRO AND IN VIVO; VIVO EVALUATION;

BIOCOMPATIBILITY;

BIOMATERIAL; HEXANE; INTERLEUKIN 1BETA; INTERLEUKIN 6; POLYESTER; SEBACIC ACID; TUMOR NECROSIS FACTOR ALPHA; VALERIC ACID DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOMEDICINE; BONE TISSUE; CELL PROLIFERATION; CELL STRAIN L 929; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXICITY TEST; DENSITY; EUTHANASIA; FIBROBLAST; FIBROBLAST CULTURE; GENERAL ANESTHESIA; HISTOLOGY; IMPLANT; IN VITRO STUDY; IN VIVO STUDY; INCUBATION TIME; INFLAMMATION; MORPHOMETRICS; MUSCLE TISSUE; NONHUMAN; POSTOPERATIVE PERIOD; RAT; RAT STRAIN; STATISTICAL ANALYSIS; SUBCUTANEOUS TISSUE; TISSUE REPAIR; VASCULARIZATION;

EID: 13644254962     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.1177/039139880402700910     Document Type: Article

References (54)

1. Yoon JJ, Kim JH, Park TG. Dexamethasone-releasing biodegradable polymer scaffolds fabricated by a gasfoaming/salt-leaching method. Biomaterials 2003; 24: 2323-9.
2. Yoshimoto H, Shin YM, Terai H, Vacanti JP. A biodegradable nanofiber scaffold by electrospinning and its potential for bone tissue engineering. Biomaterials 2003; 24: 2077-82.
3. Cao T, Ho KH, Teoh SH. Scaffold design and in vitro study of osteochondral coculture in a three-dimensional porous polycaprolactone scaffold fabricated by fused deposition modeling. Tissue Eng 2003; 9 (suppl 1): S103-12.
4. Moran JM, Pazzano D, Bonassar LJ. Characterization of polylactic acid-polyglycolic acid composites for cartilage tissue engineering. Tissue Eng 2003; 9: 63-70.
5. Kontio R, Suuronen R, Salonen O, Paukku P, Konttinen YT, Lindqvist C. Effectiveness of operative treatment of internal orbital wall fracture with polydioxanone implant. Int J Oral Maxillofac Surg 2001; 30: 278-85.
6. Vesala AL, Kallioinen M, Tormala P, Kellomaki M, Waris T, Ashammakhi N. Bone tissue engineering: treatment of cranial bone defects in rabbits using self-reinforced poly-L,D-lactide 96/4 sheets. J Craniofac Surg 2002; 13: 607-13.
7. Barber FA. Tripled semitendinosus-cancellous bone anterior cruciate ligament reconstruction with bioscrew fixation. Arthroscopy 1999; 15: 360-7.
8. Nakayama Y, Shirai Y, Narita T, Mori A. A follow-up arthroscopy after anterior cruciate ligament reconstruction using the patellar tendon augmented by woven polyester. Nippon Ika Daigaku Zasshi 1997; 64: 512-7.
9. Kazimoglu C, Bolukbasi S, Kanatli U, Senkoylu A, Altun NS, Babac C, Yavuz H,Piskin E. A novel biodegradable PCL film for tendon reconstruction: Achilles tendon defect model in rats. Int J Artif Organs 2003; 26: 804-12.
10. Senkoylu A, Ural E, Kesenci K, Simsek A, Ruacan S, Fambri L, Migliaresi C,Piskin E. Poly(D, L-lactide/epsilon-caprolactone)/hydroxyapatite composites as bone filler: An in vivo study in rats. Int J Artif Organs 2002; 25: 1174-9.
11. Giardino R, Fini M, Aldini NN, Giavaresi G, Rocca M, Martini L, Zaffe D, Cane V. A reabsorbable tubular chamber for the treatment of large diaphyseal bone defects. Experimental study in rabbits. Int J Artif Organs 1998; 21: 473-82.
12. Fini M, Giannini S, Giardino R, Giavaresi G, Grimaldi M, Aldini NN, Orienti L, Rocca M. Resorbable device for fracture fixation: In vivo degradation and mechanical behaviour. Int J Artif Organs 1995; 18: 772-6.
13. Panyam J, Labhasetwar V. Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv Drug Deliv Rev 2003; 55: 329-47.
14. Schwendeman SP. Recent advances in the stabilization of proteins encapsulated in injectable PLGA delivery systems. Crit Rev Ther Drug Carrier Syst 2002; 19: 73-98.
15. Lavasanifar A, Samuel J, Kwon GS. Poly(ethylene oxide)-block-poly(L-amino acid) micelles for drug delivery. Adv Drug Deliv Rev 2002; 54: 169-90.
16. Zinn M, Witholt B, Egli T. Occurrence, synthesis and medical application of bacterial polyhydroxyalkanoate. Adv Drug Deliv Rev 2001; 53: 5-21.
17. Rokkanen PU, Bostman O, Hirvensalo E, Makela EA, Partio EK, Patiala H, Vainionpaa SI, Vihtonen K, Tormala P. Bioabsorbable fixation in orthopaedic surgery and traumatology. Biomaterials 2000; 21: 2607-13.
18. Athanasiou KA, Agrawal CM, Barber FA, Burkhart SS. Orthopaedic applications for PLA-PGA biodegradable polymers. Arthroscopy 1998; 14: 726-37.
19. Macdonald P, Arneja S. Biodegradable screw presents as a loose intra-articular body after anterior cruciate ligament reconstruction. Arthroscopy 2003; 19: E22-4.
20. Lajtai G, Schmiedhuber G, Unger F, Aitzetmuller G, Klein M, Noszian I, Orthner E. Bone tunnel remodeling at the site of biodegradable interference screws used for anterior cruciate ligament reconstruction: 5-year follow-up. Arthroscopy 2001; 17: 597-602.
21. Hurel C, Mertens F, Verdonk R. Biofix resorbable meniscus arrow for meniscal ruptures: Results of a 1-year follow-up. Knee Surg Sports Traumatol Arthrosc 2000; 8: 46-52.
22. Hammond T. Liggat JJ. Properties and applications of baterially derived polyhydroxyalkanoates. In: Scott G, Gilead D, eds. Degradable polymers. London: Chapman & Hall, 1995: 88-111.
23. Chambers R, Daly JH, Hayward D, Liggat JJ. The effect of processing on the properties of poly(3- hydroxybutyrate-co3-hydroxyvalerate) copolymers. J Mater Sci 2001; 36: 3785-92.
24. van der Walle GA, de Koning GJ, Weusthuis RA, Eggink G. Properties, modifications and applications of biopolyesters. Adv Biochem Eng Biotechnol 2001; 71: 263-91.
25. Cox MK. Biodegradable polymers and plastics (ed. M. Vert), Royal Society of Chemistry, Cambridge, 1990.
26. Yasin M, Holland SJ, Tighe BJ. Polymers for biodegradable medical devices. V. Hydroxybutyrate-hydroxyvalerate copolymers: Effects of polymer processing on hydrolytic degradation. Biomaterials 1990; 11: 451-4.
27. Saito T, Tomita K, Juni K, Ooba K. In vivo and in vitro degradation of poly(3-hydroxybutyrate) in rat. Biomaterials 1991; 12: 309-12.
28. Gogolewski S, Jovanovic M, Perren SM, Dillon JG, Hughes MK. Tissue response and in vivo degradation of selected polyhydroxyacids: polylactides (PLA), poly(3-hydroxybutyrate) (PHB), and poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (PHB/VA). J Biomed Mater Res 1993; 27: 1135-48.
29. Holland SJ, Jolly AM, Yasin M, Tighe BJ. Polymers for biodegradable medical devices. II. Hydroxybutyrate-hydroxyvalerate copolymers: Hydrolytic degradation studies. Biomaterials 1987; 8: 289-95.
30. Gursel I, Hasirci V. Properties and drug release behaviour of poly(3-hydroxybutyric acid) and various poly(3-hydroxybutyrate-hydroxyvalerate) copolymer microcapsules. J Microencapsul 1995;12: 185-93.
31. Sendil D, Gursel I, Wise DL, Hasirci V. Antibiotic release from biodegradable PHBV microparticles. J Control Rel 1999; 59: 207-17.
32. Yagmurlu MF, Korkusuz F, Gursel I, Korkusuz P, Ors U, Hasirci V. Sulbactam-cefoperazone polyhydroxybutyrate-co-hydroxyvalerate (PHBV) local antibiotic delivery system: In vivo effectiveness and biocompatibility in the treatment of implant-related experimental osteomyelitis. J Biomed Mater Res 1999; 46: 494-503.
33. Gursel I, Korkusuz F, Turesin F, Alaeddinoglu NG, Hasirci V. In vivo application of biodegradable controlled antibiotic release systems for the treatment of implant-related osteomyelitis. Biomaterials 2001; 22: 73-80.
34. Khang G, Kim SW, Cho JC, Rhee JM, Yoon SC, Lee HB. Preparation and characterization of poly(3-hydroxybutyrate-co-3-hydroxyvalerate) microspheres for the sustained release of 5-fluorouracil. Biomed Mater Eng 2001; 11: 89-103.
35. Turesin F, Gursel I, Hasirci V. Biodegradable polyhydroxyalkanoate implants for osteomyelitis therapy: In vitro antibiotic release. J Biomater Sci Polym Ed 2001; 12: 195-207.
36. Gurselt I, Yagmurlu F, Korkusuz F, Hasirci V. In vitro antibiotic release from poly(3-hydroxybutyrate-co-3-hydroxyvalerate) rods. J Microencapsul 2002; 19: 153-64.
37. Chen J, Davis SS. The release of diazepam from poly(hydroxybutyrate-hydroxyvalerate) microspheres. J Microencapsul 2002; 19: 191-201.
38. Baran ET, Ozer N, Hasirci V. Poly(hydroxybutyrate-co-hydroxyvalerate) nanocapsules as enzyme carriers for cancer therapy: An in vitro study. J Microencapsul 2002; 19: 363-76.
39. Galgut P, Pitrola R, Waite I, Doyle C, Smith R. Histological evaluation of biodegradable and non-degradable membranes placed transcutaneously in rats. J Clin Periodontol 1991; 18: 581-6.
40. Kose GT, Kenar H, Hasirci N, Hasirci V. Macroporous poly(3-hydroxybutyrate-co-3-hydroxyvalerate) matrices for bone tissue engineering. Biomaterials 2003; 24: 1949-58.
41. Hu SG, Jou CH, Yang MC. Protein adsorption, fibroblast activity and antibacterial properties of poly(3-hydroxybutyric acid-co-3-hydroxyvaleric acid) grafted with chitosan and chitooligosaccharide after immobilized with hyaluronic acid. Biomaterials 2003; 24: 2685-93.
42. Doyle C, Tanner ET, Bonfield W. In vitro and in vivo evaluation of polyhydroxybutyrate and of polyhydroxybutyrate reinforced with hydroxyapatite. Biomaterials 1991; 12: 841-7.
43. Knowles JC. Development of a natural degradable polymer for orthopaedic use. J Med Eng Technol 1993; 17: 129-37.
44. Chen A, Hou C, Gou S. Distal clavicular fracture and dislocation of acromino-clavicular joint treated with biopoly ligament. Zhonghua Wai Ke Za Zhi 1998; 36: 96-7.
45. Chen LJ, Wang M. Production and evaluation of biodegradable composites based on PHB-PHV copolymer. Biomaterials 2002; 23: 2631-9.
46. Luklinska ZB, Schluckwerder H. In vivo response to HA-polyhydroxybutyrate/polyhydroxyvalerate composite. J Microsc 2003; 211: 121-9.
47. Braun D, Hempler P. Grafting of polyesters by free-radical chain transfer. Die Angewandte Makromol Chemie 1993; 210: 173-96.
48. Hutcheon GA, Messiou C, Wyre RM, Davies MC, Downes S. Water absorption and surface properties of novel poly(ethylmethacrylate) polymer systems for use in bone and cartilage repair. Biomaterials 2001; 22: 667-76.
49. Kirkpatrick CJ. Endothelial cell cultures as a tool in biomaterial research. J Mater Sci Mater Med 1999; 10: 589-91.
50. Castner DG, Ratner BD. Biomedical surface science: Foundations to frontiers. Surf Sci 2002; 500: 28-60.
51. Ratner BD. Reducing capsular thickness and enhancing angiogenesis around implant drug release systems. J Control Rel 2002; 78: 211-8.
52. Fini M, Giardino R. In vitro and in vivo tests for the histological evaluation of candidate orthopaedic materials: benefit and limits. Journal of Applied Biomaterials and Biomechanics 2003; 1: 155-63.
53. Gowen M. Interleukin 1 and tumor necrosis factor. In: Gowen M, ed. Cytokines and bone metabolism. Boca Raton: CRC Press. Inc.; 1992: pp. 71-91.
54. Wang Y, Kim YM, Langer R. In vivo degradation characteristics of poly(glycerol sebacate). J Biomed Mater Res 2003; 66: 192-7.